These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16706246)

  • 1. A novel aqueous metronidazole 1% gel with hydrosolubilizing agents (HSA-3).
    Dow G; Basu S
    Cutis; 2006 Apr; 77(4 Suppl):18-26. PubMed ID: 16706246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A look at the safety of metronidazole 1% gel: cumulative irritation, contact sensitization, phototoxicity, and photoallergy potential.
    Beutner KR; Lemke S; Calvarese B
    Cutis; 2006 Apr; 77(4 Suppl):12-7. PubMed ID: 16706245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea.
    Wolf JE; Kerrouche N; Arsonnaud S
    Cutis; 2006 Apr; 77(4 Suppl):3-11. PubMed ID: 16706244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
    Elewski BE; Fleischer AB; Pariser DM
    Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The appearance of facial foundation cosmetics applied after metronidazole gel 1%.
    Draelos ZD; Colón LE; Preston N; Johnson LA; Gottschalk RW
    Cutis; 2011 May; 87(5):251-9. PubMed ID: 21699130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea.
    Laquieze S; Czernielewski J; Baltas E
    J Dermatolog Treat; 2007; 18(3):158-62. PubMed ID: 17538804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of skin barrier function in rosacea patients with a novel 1% metronidazole gel.
    Draelos ZD
    J Drugs Dermatol; 2005; 4(5):557-62. PubMed ID: 16167413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%.
    Colón LE; Johnson LA; Gottschalk RW
    Cutis; 2007 Apr; 79(4):317-21. PubMed ID: 17500380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 15% azelaic acid gel and 0.75% metronidazole gel for the topical treatment of papulopustular rosacea.
    Czernielewski J; Liu Y
    Arch Dermatol; 2004 Oct; 140(10):1282-3; author reply 1283. PubMed ID: 15492198
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of a novel rosacea treatment system: an investigator-blind, randomized, parallel-group study.
    Leyden JJ
    J Drugs Dermatol; 2011 Oct; 10(10):1179-85. PubMed ID: 21968669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gel vehicles are not inherently more irritating than creams.
    Kirkland CR; Yelverton CB; Fleischer AB; Camacho FT; Feldman SR
    J Drugs Dermatol; 2006 Mar; 5(3):269-72. PubMed ID: 16573261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical overview of azelaic acid.
    Elewski B; Thiboutot D
    Cutis; 2006 Feb; 77(2 Suppl):12-6. PubMed ID: 16566283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.
    Dahl MV; Jarratt M; Kaplan D; Tuley MR; Baker MD
    J Am Acad Dermatol; 2001 Nov; 45(5):723-30. PubMed ID: 11606923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adapalene vs. metronidazole gel for the treatment of rosacea.
    Altinyazar HC; Koca R; Tekin NS; Eştürk E
    Int J Dermatol; 2005 Mar; 44(3):252-5. PubMed ID: 15807740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea.
    Wolf JE; Del Rosso JQ
    Cutis; 2007 Jan; 79(1):73-80. PubMed ID: 17330626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosacea: update on management and emerging therapies.
    Fallen RS; Gooderham M
    Skin Therapy Lett; 2012 Dec; 17(10):1-4. PubMed ID: 23223767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical metronidazole maintains remissions of rosacea.
    Dahl MV; Katz HI; Krueger GG; Millikan LE; Odom RB; Parker F; Wolf JE; Aly R; Bayles C; Reusser B; Weidner M; Coleman E; Patrignelli R; Tuley MR; Baker MO; Herndon JH; Czernielewski JM
    Arch Dermatol; 1998 Jun; 134(6):679-83. PubMed ID: 9645635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.
    Fowler J; Jackson M; Moore A; Jarratt M; Jones T; Meadows K; Steinhoff M; Rudisill D; Leoni M
    J Drugs Dermatol; 2013 Jun; 12(6):650-6. PubMed ID: 23839181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):s101-7. PubMed ID: 25607798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosacea and its topical management.
    Gooderham M
    Skin Therapy Lett; 2009 Feb; 14(2):1-3. PubMed ID: 19330270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.